Skip to content

Column Group LLC

Follow

13F filer, CIK 1833486, San Francisco, CA

Column Group LLC reported $124,293,394 across 3 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16.

Accepted , ingested 13F-HR 0001193125-26-463528

Period
2026-09-30
Reported value
$124M
Holdings
3
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SRZNnew+2,951,433$76.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
Surrozen, Inc.exited-1,916,950-$49.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001193125-26-463528, largest first. % of portfolio is the value over $124,293,394, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,951,433 shares 2,951,433$76.6M61.62%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,540,777 shares; 2025Q1: 3,540,777 shares; 2025Q2: 3,540,777 shares; 2025Q3: 3,540,777 shares; 2025Q4: 3,540,777 shares; 2026Q1: 3,540,777 shares; 2026Q2: 3,540,777 shares; 2026Q3: 3,540,777 shares 3,540,777$47.7M38.37%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 46 shares; 2025Q1: 46 shares; 2025Q2: 46 shares; 2025Q3: 46 shares; 2025Q4: 46 shares; 2026Q1: 46 shares; 2026Q2: 46 shares; 2026Q3: 46 shares 46$9.44K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
Surrozen, Inc.Surrozen, Inc.1,916,950$49.7Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-463528 base2026-11-16

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001193125-26-463528 Quarter ended 2026-09-302026-11-16
13F-HR 0001193125-26-352333 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001193125-26-227853 Quarter ended 2026-03-312026-05-18acceptance time not in the bulk data set
13F-HR 0001193125-26-051393 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001193125-25-282923 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000950123-25-008462 Quarter ended 2025-06-302025-08-15acceptance time not in the bulk data set
13F-HR 0000950123-25-005219 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0000950123-25-002782 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000950123-24-011839 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0000950123-24-008866 Quarter ended 2024-06-302024-08-15acceptance time not in the bulk data set
13F-HR 0000950123-24-005685 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000950123-24-001345 Quarter ended 2023-12-312024-02-09acceptance time not in the bulk data set
13F-HR 0000950123-23-010234 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0000950123-23-006249 Quarter ended 2023-06-302023-07-24acceptance time not in the bulk data set
13F-HR 0000950123-23-005442 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000950123-23-001984 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0000950123-22-012332 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0000950123-22-008866 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0000950123-22-006494 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0000950123-22-002163 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0000950123-21-014990 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0000950123-21-011535 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0000950123-21-007096 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0000950123-21-002050 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set